Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide

Anne M Fitzpatrick1, Benjamin M Gaston, Serpil C Erzurum

  • 1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA. anne.fitzpatrick@emory.edu

Insights

Severe asthma in children presents with persistent symptoms despite inhaled corticosteroid (ICS) treatment. Differentiating severe asthma involves assessing lung function, atopy, and airway inflammation, particularly exhaled nitric oxide (F(ENO)).

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Respiratory Medicine

Background:

  • Severe asthma in children often persists despite inhaled corticosteroid (ICS) therapy.
  • Distinctive features differentiating severe pediatric asthma remain poorly defined.
  • Understanding these features is crucial for effective management and treatment strategies.

Purpose of the Study:

  • To identify key characteristics distinguishing severe from mild-to-moderate asthma in school-aged children.
  • To utilize noninvasive assessments including lung function, atopy, and airway inflammation markers.
  • To establish objective criteria for diagnosing severe asthma in pediatric populations.

Main Methods:

  • Seventy-five school-aged children with asthma underwent comprehensive assessments.
  • Evaluations included spirometry, lung volume testing, methacholine challenge, allergy testing, and exhaled nitric oxide (F(ENO)) measurement.
  • Participants were classified into severe or mild-to-moderate asthma groups based on ICS dosage and clinical criteria.

Main Results:

  • Children with severe asthma exhibited increased symptoms, greater airway obstruction, and heightened bronchial responsiveness.
  • Higher exhaled nitric oxide (F(ENO)) levels and significant aeroallergen sensitization were observed in the severe asthma group.
  • Despite ICS adjustments, severe asthma was associated with more frequent exacerbations and persistent lung function deficits.

Conclusions:

  • Severe childhood asthma is characterized by poor symptom control and high-dose ICS requirement.
  • Lung function parameters and exhaled nitric oxide (F(ENO)) levels effectively differentiate severe from mild-to-moderate pediatric asthma.
  • Clinicians should consider severe asthma in children with ICS non-response, airway obstruction, and elevated F(ENO).
Abstract

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...